Japan biotech venture PeptiDream a US$3b business
Tokyo
WHEN he realised he wasn't going to make it as a guitarist, Hiroaki Suga set out to find the origin of life, and ended up creating a new way to develop medicines.
Many years spent fiddling with the building blocks of the universe - combining molecules to form compounds - led to Prof Suga developing an enzyme that opened the door to a faster method of discovering drugs. PeptiDream Inc, the company he co-founded, has inked deals with many of the world's biggest pharma firms, and shares have surged more than ninefold since listing in 2013.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
Cordlife served letter of demand, notice of claim from customers
IndoAgri appoints former EDB chairman Philip Yeo as chairman and lead independent director
GSK profit drops 23% in Q1 on higher costs
Starbucks points to weaker consumer as profit falls
Restaurant Brands tops estimates as Burger King overhaul pays off
Walmart to shut all health centers in US over lack of profitability